پنجشنبه 6 اردیبهشت 1403
[Archive]
دوره 7، شماره 4 - ( 4-1388 )
جلد 7 شماره 4 صفحات 180-175 |
برگشت به فهرست نسخه ها
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Aleyasin A, Aghahosseini M, Mohseni M, Mahdavi A. Effects of pentoxifylline and vitamin E on pregnancy rate in infertile women treated by ZIFT: a randomized clinical trial. IJRM 2009; 7 (4) :175-180
URL: http://ijrm.ir/article-1-162-fa.html
URL: http://ijrm.ir/article-1-162-fa.html
Effects of pentoxifylline and vitamin E on pregnancy rate in infertile women treated by ZIFT: a randomized clinical trial. International Journal of Reproductive BioMedicine. 1388; 7 (4) :175-180
چکیده: (2701 مشاهده)
Background: Reviewing the literature reveals that pentoxifylline (PTX) plus tocopherol (vitamin E) are used mainly to promote sperm quality. However trials focusing on the effects of these drugs in female partner are limited. Combination of pentoxifylline and vitamin E appeared to improve the pregnancy rate in patients with a thin endometrium by increasing the endometrial thickness and improving ovarian function.
Objective: To determine whether combined PTX and tocopherol treatment can improve clinical pregnancy rate.
Materials and Methods: One hundred twelve infertile women undergoing standardized controlled ovarian hyperstimulation for ICSI- ZIFT entered this randomized clinical trial. Patients were randomized to equal groups of combined PTX and tocopherol therapy or none (not receiving PTX and tocopherol). These drugs were administered to the intervention group for two cycles before starting ICSI-ZIFT cycle. Main outcome measure was clinical pregnancy rate. SPSS.11 software (SPSS Inc. Chicago IL.) was used for data collection and analysis.
Results: The clinical pregnancy was higher in the intervention (combined PTX and tocopherol) group in comparison to the other group (57.14% vs 39.29% p=0.01). However there was no difference in the mean endometrial thickness number of retrieved oocytes the number of metaphase II oocytes and grade of them in both groups.
Conclusion: This study showed that PTX plus tocopherol could improve the ZIFT outcome in infertile couples. Local effects and anti oxidative characteristics of these drugs may be the cause of better results.
Objective: To determine whether combined PTX and tocopherol treatment can improve clinical pregnancy rate.
Materials and Methods: One hundred twelve infertile women undergoing standardized controlled ovarian hyperstimulation for ICSI- ZIFT entered this randomized clinical trial. Patients were randomized to equal groups of combined PTX and tocopherol therapy or none (not receiving PTX and tocopherol). These drugs were administered to the intervention group for two cycles before starting ICSI-ZIFT cycle. Main outcome measure was clinical pregnancy rate. SPSS.11 software (SPSS Inc. Chicago IL.) was used for data collection and analysis.
Results: The clinical pregnancy was higher in the intervention (combined PTX and tocopherol) group in comparison to the other group (57.14% vs 39.29% p=0.01). However there was no difference in the mean endometrial thickness number of retrieved oocytes the number of metaphase II oocytes and grade of them in both groups.
Conclusion: This study showed that PTX plus tocopherol could improve the ZIFT outcome in infertile couples. Local effects and anti oxidative characteristics of these drugs may be the cause of better results.
نوع مطالعه: Original Article |
فهرست منابع
1. Lédée-Bataille N, Olivennes F, Lefaix J-L, Chaouat G, Frydman R, Delanian S. Combined treatment by pentoxifylline and tocopherol for recipient women with a thin endometrium enrolled in an oocyte donation programme. Human Reproduction 2002; 17: 1249-1253. [DOI:10.1093/humrep/17.5.1249]
2. Letur-Könirsch H, Guis F, Delanian S. Uterine restoration by radiation sequelae regression with combined pentoxifylline-tocopherol: a phase II study. Fertil Steril 2002; 77:1219-1226. [DOI:10.1016/S0015-0282(02)03120-5]
3. Lefaix JL, Delanian S, Vozenin MC, Leplat JJ, Tricaud Y, Martin M. Striking regression of subcutaneous fibrosis induced by high doses of gamma rays using a combination of pentoxifylline and alpha-tocopherol: an experimental study. Int J Radiat Oncol Biol Phys 1999; 43: 839-847. [DOI:10.1016/S0360-3016(98)00419-2]
4. Zhang X, Sharma RK, Agarwal A, Falcone T. Antioxidant effect of pentoxifylline in reducing oxidative stress induced embryotoxicity. Fertil and Steril 2004; 82: 324-325. [DOI:10.1016/j.fertnstert.2004.07.878]
5. Samlaska CP, Winfield EA. Pentoxifylline. J Am Acad Dermatol 1994; 30: 603-621. [DOI:10.1016/S0190-9622(94)70069-9]
6. Chaouat G, Menu E, Delage G, Moreau JF, Khrishnan L, Hui L, et al. Immuno-endocrine interactions in early pregnancy. Hum Reprod 1995; 10: 55-59. [DOI:10.1093/humrep/10.suppl_2.55]
7. Wegmann TG, Guilbert LJ. Immune signalling at the maternal-fetal interface and trophoblast differentiation. Dev Comp Immunol 1992; 16: 425-430. [DOI:10.1016/0145-305X(92)90026-9]
8. Maruyama T, Kitaoka Y, Sachi Y, Nakanoin K, Hirota K, Shiozawa T, et al. Thioredoxin expression in the human endometrium during the menstrual cycle. Mol Hum Reprod 1997; 3: 989-993. [DOI:10.1093/molehr/3.11.989]
9. Stark JM. Inadequate reducing systems in pre-eclampsia: a complementary role for vitamins C and E with thioredoxin-related activities. BJOG 2001; 108: 339-343. [DOI:10.1016/S0306-5456(00)00100-5]
10. Delanian S, Balla-Mekias S, Lefaix JL. Striking regression of chronic radiotherapy damage in a clinical trial of combined pentoxifylline and tocopherol. Journal of Clinical Oncology 1999; 17: 3283-3290. [DOI:10.1200/JCO.1999.17.10.3283]
11. Okusami AA, Moore ME, Hurwitz JM, Richlin SS, Leondires MP. A case series of patients with endometrial insufficiency treated with pentoxifylline and alphatocopherol. Fertil and Steril 2007; 88: 276. [DOI:10.1016/j.fertnstert.2007.07.684]
12. Yogev L, Gamuz R, Botchan A, Homonnai ZT, Amit A, Lessing JB, et al. Pentoxifylline improves sperm binding to the zona pellucida in the hemizona assay. Fertil Steril 1995; 64:146-149. [DOI:10.1016/S0015-0282(16)57671-7]
13. Senturk LM, Erel CT. Thin endometrium in assisted reproductive technology. Curr Opin Obstet Gynecol 2008; 20:221-228. [DOI:10.1097/GCO.0b013e328302143c]
| بازنشر اطلاعات | |
 |
این مقاله تحت شرایط Creative Commons Attribution-NonCommercial 4.0 International License قابل بازنشر است. |
